[1]
Shivalingaiah, A.H. et al. 2018. Safety of new indigenous human Rabies Monoclonal Antibody (RMAb) for Post Exposure Prophylaxis. Indian Journal of Community Health. 30, 3 (Sep. 2018), 196–201. DOI:https://doi.org/10.47203/IJCH.2018.v30i03.004.